Invest in Catalent CTLT

Catalent, Inc. is a holding company which engages in the provision of delivery technologies, development and manufacturing solutions for drugs, biologics, cell & gene therapies and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery and Clinical Supply Services. The Softgel and Oral Technologies segment offers formulation, development and manufacturing services for soft capsules or softgels, as well as the large-scale production of oral solid dose forms for the pharmaceutical and consumer health markets and their supporting ancillary services. The Biologics segment develops and produces biologic cell-line, cell therapy and viral vector gene therapy, formulation for parenteral dose forms which include prefilled syringes, vials, and cartridges, and analytical development and testing services for large molecules. The Oral and Specialty Delivery segment consists of advanced formulation of a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment involves packaging, storage, distribution and inventory management for drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ.